Treatment of tuberculosis.
D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D003365:Costs and Cost Analysis; D004342:Drug Hypersensitivity / Q000209:etiology; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D009902:Optic Neuritis / Q000139:chemically induced; D011247:Pregnancy; D012294:Rifamycins / Q000009:adverse effects / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D012294:Rifamycins; D004977:Ethambutol; D007538:Isoniazid